LEG
20
2
PAYX
57
3
HUM
45
2
BDX
59
10
HSY
67
3
BXP
57
2
EBAY
47
3
GS
80
8
AMZN
74
7
SYF
95
-4
ADI
68
2
BA
50
-2
CME
52
-7
DTE
50
-6
AES
69
-10
VFC
22
-4
O
44
4
NWSA
71
2
STI
35
-11
AIZ
69
-7
LEG
20
2
PAYX
57
3
HUM
45
2
BDX
59
10
HSY
67
3
BXP
57
2
EBAY
47
3
GS
80
8
AMZN
74
7
SYF
95
-4
ADI
68
2
BA
50
-2
CME
52
-7
DTE
50
-6
AES
69
-10
VFC
22
-4
O
44
4
NWSA
71
2
STI
35
-11
AIZ
69
-7
Financhill
Back

United Therapeutics Quote, Financials, Valuation and Earnings

I love this overnight trade happening Thursday

Access my free presentation on these overnight trades right here
Buy
55

UTHR
United Therapeutics

Last Price:
264.33
Seasonality Move:
10.48%

7 Day Trial

ALL ACCESS PASS

$ 7

$50 trade to make today with huge potential!

Click here to access my #1 options strategy for overnight wins starting with $50!

United Therapeutics Price Quote

$264.33
+0.06 (+-0.59%)
(Updated: May 11, 2024 at 6:31 AM ET)

United Therapeutics Key Stats

Buy
55
United Therapeutics (UTHR) is a Buy
Day range:
$263.93 - $269.81
52-week range:
$204.44 - $269.81
Dividend yield:
0%
P/E ratio:
13.34
P/S ratio:
5.26
P/B ratio:
2.2%
Volume:
391.7K
Avg. volume:
552.5K
1-year change:
24.51%
Market cap:
$11.7B
Revenue:
$2.3B
EPS:
$21.15

How Much Does United Therapeutics Make?

Is United Therapeutics Growing As A Company?

  • What Is United Therapeutics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.34%
  • What Is United Therapeutics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0.27%

United Therapeutics Stock Price Performance

What Is United Therapeutics 52-Week High & Low?

United Therapeutics Price To Free Cash Flow

Is It Risky To Buy United Therapeutics?

Is United Therapeutics Cash Flow Positive?

  • What Is UTHR Cash Flow From Operations?
    Cash flow from operations (TTM) is $979.7M
  • What Is United Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$1.1B
  • What Is United Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $236.8M

United Therapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    UTHR return on invested capital is 16.8%
  • What Is United Therapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is 15.58%
  • What Is UTHR Return On Equity?
    ROE is a measure of profitability and is 19.05%

United Therapeutics Earnings Date & Stock Price

United Therapeutics Competitors

  • Who Are United Therapeutics's Competitors?
    Below is a list of companies who compete with United Therapeutics or are related in some way:
    • Esperion Therapeutics Inc (ESPR)
    • Heron Therapeutics Inc (HRTX)
    • Ligand Pharmaceuticals Inc (LGND)
    • Liquidia Corp (LQDA)
    • Vertex Pharmaceuticals Inc (VRTX)

United Therapeutics Dividend Yield

Data Unavailable

United Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 26.96% 10.31%
Revenue: 33.7% 8.57%

Analyst Recommendations

Buy Recommendations: 8
Hold Recommendations: 3
Sell Recommendations: 0
Price Target: 292.74
Upside from Last Price: 10.77%

Major Shareholders

  • How many UTHR shares are owned by institutional investors?
    70.6M UTHR shares are owned by institutional investors
  • How many UTHR shares are owned by insiders?
    114.8K UTHR shares are owned by insiders